[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biolife Solutions (BLFS)

Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,373,370
  • Shares Outstanding, K 48,857
  • Annual Sales, $ 96,210 K
  • Annual Income, $ -4,600 K
  • EBIT $ -16 M
  • EBITDA $ -11 M
  • 60-Month Beta 1.94
  • Price/Sales 14.47
  • Price/Cash Flow 122.76
  • Price/Book 3.69

Options Overview Details

View History
  • Implied Volatility 79.19% (-5.04%)
  • Historical Volatility 46.48%
  • IV Percentile 25%
  • IV Rank 22.26%
  • IV High 188.31% on 03/26/26
  • IV Low 47.95% on 06/17/26
  • Expected Move (DTE 10) 0.85 (3.06%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 528
  • Put/Call OI Ratio 0.50
  • Today's Open Interest 1,783
  • Open Int (30-Day) 4,617
  • Expected Range 26.94 to 28.64

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.02
  • Number of Estimates 1
  • High Estimate $-0.02
  • Low Estimate $-0.02
  • Prior Year $0.00
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.76 +12.21%
on 06/24/26
30.00 -7.37%
on 06/29/26
+1.14 (+4.28%)
since 06/05/26
3-Month
18.59 +49.45%
on 04/07/26
30.00 -7.37%
on 06/29/26
+8.52 (+44.21%)
since 04/06/26
52-Week
17.86 +55.60%
on 03/13/26
30.00 -7.37%
on 06/29/26
+4.95 (+21.67%)
since 07/03/25

Most Recent Stories

More News
BioLife Solutions Q1 Earnings Call Highlights

BioLife Solutions (NASDAQ:BLFS) reported first-quarter 2026 revenue of $27.5 million, up 25% year-over-year, as management pointed to continued strength in its biopreservation media (BPM) franchise and...

BLFS : 27.79 (-1.14%)
BioLife Solutions Reports First Quarter 2026 Financial Results

Total revenue of $27.5 million, up 25% over Q1 2025

BLFS : 27.79 (-1.14%)
BioLife Solutions to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026

BOTHELL, Wash. , April 23, 2026 /PRNewswire/ -- BioLife Solutions, Inc.  (NASDAQ: BLFS ), a leading developer and supplier of bioproduction products and services for the cell and gene therapy...

BLFS : 27.79 (-1.14%)
BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations

Fourth quarter 2025  revenue from continuing operations of $24.8 million, up 20% year-over-year; Full year   2025 revenue of $96.2 million, up 29% year-over-year

BLFS : 27.79 (-1.14%)
BioLife Solutions to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 26, 2026

BOTHELL, Wash. , Feb. 17, 2026 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy...

BLFS : 27.79 (-1.14%)
BioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines Market

BOTHELL, Wash. , Feb. 12, 2026 /PRNewswire/ --  BioLife Solutions, Inc. (NASDAQ: BLFS ), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy...

BLFS : 27.79 (-1.14%)
BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2025 Unaudited Revenue from Continuing Operations

Fourth quarter unaudited revenue from continuing operations of $24.8 million increased 20% from the prior year fourth quarter

BLFS : 27.79 (-1.14%)
BioLife Solutions Unveils the Aby J. Mathew Center for Biopreservation Excellence

New conference and laboratory facility to showcase the company's product portfolio and serve as a research and training hub to advance biopreservation and cell processing innovation

BLFS : 27.79 (-1.14%)
BioLife Solutions to Participate in Upcoming Investor Conferences in November and December 2025

BOTHELL, Wash. , Nov. 17, 2025 /PRNewswire/ -- BioLife Solutions , Inc.  (NASDAQ: BLFS ), a leading developer and supplier of bioproduction products and services for the...

BLFS : 27.79 (-1.14%)
BioLife Solutions Reports Third Quarter 2025 Financial Results

Cell Processing revenue of $25.4 million, up 33% over Q3 2024

BLFS : 27.79 (-1.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of...

See More

Key Turning Points

3rd Resistance Point 29.21
2nd Resistance Point 28.78
1st Resistance Point 28.29
Last Price 27.79
1st Support Level 27.37
2nd Support Level 26.94
3rd Support Level 26.45

See More

52-Week High 30.00
Last Price 27.79
Fibonacci 61.8% 25.36
Fibonacci 50% 23.93
Fibonacci 38.2% 22.50
52-Week Low 17.86

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.